MONDOBIOTECH AG has a total of 12 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, EPO (European Patent Office) and Hong Kong. Its main competitors in its focus markets pharmaceuticals and biotechnology are PROXIMAGEN GROUP LTD, FX LIFE SCIENCES INTERNAT GMBH and BIOINNOVATION LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Hong Kong | 1 | |
#4 | Norway | 1 | |
#5 | New Zealand | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Bevec Dorian | 10 |
#2 | Bacher Gerald | 3 |
#3 | Block Lutz-Henning | 2 |
#4 | Ziesche Rolf | 1 |
Publication | Filing date | Title |
---|---|---|
AU2006222233A1 | Formulation for aviptadil | |
AU2004255379A1 | Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections | |
AU2003236072A1 | Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis | |
EP1455813A2 | Interferon gamma in combination with a diagnostic array for use in the improved treatment of idiopathic pulmonary fibrosis |